Mouse adenovirus type 1-induced breakdown of the blood-brain barrier

Journal of Virology

Volumn 83, Issue 18, 2009, Pages 9398-9410

  Gralinski, Lisa E ^a,b   Ashley, Shanna L ^a   Dixon, Shandee D ^a   Spindler, Katherine R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CLAUDIN 5; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OCCLUDIN; RANTES; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZONA OCCLUDENS 2 PROTEIN;

ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CELL FUNCTION; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; INFLAMMATION; MALE; MOUSE; MOUSE ADENOVIRUS TYPE 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENCEPHALITIS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CHEMOKINE CCL2; CONNEXINS; DOWN-REGULATION; ENDOTHELIAL CELLS; IMMEDIATE-EARLY PROTEINS; INFLAMMATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; TIGHT JUNCTIONS;

MURINE ADENOVIRUS 1; MUS;

EID: 69449093569     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00954-09     Document Type: Article

References (87)

1. Afonso, P. V., S. Ozden, M. C. Cumont, D. Seilhean, L. Cartier, P. Rezaie, S. Mason, S. Lambert, M. Huerre, A. Gessain, P. O. Couraud, C. Pique, P. E. Ceccaldi, and I. A. Romero. 2008. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog. 4:e1000205.
2. Afonso, P. V., S. Ozden, M. C. Prevost, C. Schmitt, D. Seilhean, B. Weksler, P. O. Couraud, A. Gessain, I. A. Romero, and P. E. Ceccaldi. 2007. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J. Immunol. 179:2576-2583.
3. Andersen, I. H., O. Marker, and A. R. Thomsen. 1991. Breakdown of blood-brain barrier function in the murine lymphocytic choriomeningitis virus infection mediated by virus-specific CD8+ T cells. J. Neuroimmunol. 31:155-163.
4. Andras, I. E., H. Pu, J. Tian, M. A. Deli, A. Nath, B. Hennig, and M. Toborek. 2005. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J. Cereb. Blood Flow Metab. 25:1159-1170.
5. Asahi, M., X. Wang, T. Mori, T. Sumii, J. C. Jung, M. A. Moskowitz, M. E. Fini, and E. H. Lo. 2001. Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21:7724-7732.
6. Ashley, S. L., A. R. Welton, K. M. Harwood, N. Van Rooijen, and K. R. Spindler. 2009. Mouse adenovirus type 1 infection of macrophages. Virology 390:307-314.
7. Ball, A. O., C. W. Beard, P. Villegas, and K. R. Spindler. 1991. Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1. Virology 180:257-265.
8. Bookout, A. L., and D. J. Mangelsdorf. 2003. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1:e012.
9. Campanella, M., C. Sciorati, G. Tarozzo, and M. Beltramo. 2002. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33:586-592. (Pubitemid 34123411)
10. Cauthen, A. N., C. C. Brown, and K. R. Spindler. 1999. In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 mutant. J. Virol. 73:8640-8646.
11. Cauthen, A. N., and K. R. Spindler. 1999. Novel expression of mouse adenovirus type 1 early region 3 gp11K at late times after infection. Virology 259:119-128.
12. Cauthen, A. N., A. R. Welton, and K. R. Spindler. 2007. Construction of mouse adenovirus type 1 mutants. Methods Mol. Med. 130:41-59.
13. Charles, P. C., J. D. Guida, C. F. Brosnan, and M. S. Horwitz. 1998. Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245:216-228.
14. Charo, I. F., and M. B. Taubman. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95:858-866.
15. Collins, N. T., P. M. Cummins, O. C. Colgan, G. Ferguson, Y. A. Birney, R. P. Murphy, G. Meade, and P. A. Cahill. 2006. Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function. Arterioscler. Thromb. Vasc. Biol. 26:62-68.
16. Dai, J., P. Wang, F. Bai, T. Town, and E. Fikrig. 2008. ICAM-1 participates in the entry of West Nile virus into the central nervous system. J. Virol. 82:4164-4168.
17. Dallasta, L. M., L. A. Pisarov, J. E. Esplen, J. V. Werley, A. V. Moses, J. A. Nelson, and C. L. Achim. 1999. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1915-1927.
18. Davis, D., P. J. Henslee, and W. R. Markesbery. 1988. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann. Neurol. 23:385-389.
19. de Vries, H. E., M. C. Blom-Roosemalen, M. van Oosten, A. G. de Boer, T. J. van Berkel, D. D. Breimer, and J. Kuiper. 1996. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:37-43. (Pubitemid 26052072)
20. Dobrogowska, D. H., and A. W. Vorbrodt. 2004. Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier. J. Mol. Histol. 35:529-539.
21. Dubberke, E. R., B. Tu, D. J. Rivet, G. A. Storch, A. Apisarnthanarak, R. E. Schmidt, S. Weiss, and L. B. Polish. 2006. Acute meningoencephalitis caused by adenovirus serotype 26. J. Neurovirol. 12:235-240.
22. Echavarria, M. 2008. Adenoviruses in immunocompromised hosts. Clin. Microbiol. Rev. 21:704-715.
23. Eugenin, E. A., K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman. 2006. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIVCNS invasion and neuroAIDS. J. Neurosci. 26:1098-1106.
24. Fang, L., and K. R. Spindler. 2005. E1A-CR3 interaction-dependent and -independent functions of mSur2 in viral replication of early region 1A mutants of mouse adenovirus type 1. J. Virol. 79:3267-3276. (Pubitemid 40327916)
25. Fanning, A. S., B. J. Jameson, L. A. Jesaitis, and J. M. Anderson. 1998. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273:29745-29753.
26. 2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol. 84:687-697.
27. Gabrielson, M. O., C. Joseph, and G. D. Hsiung. 1966. Encephalitis associated with adenovirus type 7 occurring in a family outbreak. J. Pediat. 68:142-144.
28. Gaillard, P. J., L. H. Voorwinden, J. L. Nielsen, A. Ivanov, R. Atsumi, H. Engman, C. Ringbom, A. G. de Boer, and D. D. Breimer. 2001. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 12:215-222.
29. Gonzalez-Mariscal, L., R. Tapia, and D. Chamorro. 2008. Crosstalk of tight junction components with signaling pathways. Biochim. Biophys. Acta 1778:729-756.
30. Gottardi, C. J., M. Arpin, A. S. Fanning, and D. Louvard. 1996. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc. Natl. Acad. Sci. USA 93:10779-10784.
31. Grabner, R., U. Till, and R. Heller. 2000. Flow cytometric determination of E-selectin, vascular cell adhesion molecule-1, and intercellular cell adhesion molecule-1 in formaldehyde-fixed endothelial cell monolayers. Cytometry 40:238-244. (Pubitemid 30441527)
32. Guida, J. D., G. Fejer, L.-A. Pirofski, C. F. Brosnan, and M. S. Horwitz. 1995. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 69:7674-7681.
33. Harkness, K. A., P. Adamson, J. D. Sussman, G. A. Davies-Jones, J. Greenwood, and M. N. Woodroofe. 2000. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123:698-709. (Pubitemid 30162719)
34. Hawkins, B. T., and T. P. Davis. 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57:173-185.
35. Hirase, T., J. M. Staddon, M. Saitou, Y. Ando-Akatsuka, M. Itoh, M. Furuse, K. Fujimoto, S. Tsukita, and L. L. Rubin. 1997. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110:1603-1613. (Pubitemid 27338748)
36. Horwitz, M. S. 2001. Adenovirus immunoregulatory genes and their cellular targets. Virology 279:1-8.
37. Ishizaki, T., H. Chiba, T. Kojima, M. Fujibe, T. Soma, H. Miyajima, K. Nagasawa, I. Wada, and N. Sawada. 2003. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp. Cell Res. 290:275-288.
38. Islas, S., J. Vega, L. Ponce, and L. Gonzalez-Mariscal. 2002. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp. Cell. Res. 274:138-148.
39. Itoh, M., K. Morita, and S. Tsukita. 1999. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and α catenin. J. Biol. Chem. 274:5981-5986.
40. Jou, T. S., E. E. Schneeberger, and W. J. Nelson. 1998. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J. Cell Biol. 142:101-115.
41. Kajon, A. E., C. C. Brown, and K. R. Spindler. 1998. Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J. Virol. 72:1219-1223.
42. Kanmogne, G. D., C. Primeaux, and P. Grammas. 2005. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 64:498-505.
43. Karpus, W. J., K. J. Kennedy, B. T. Fife, J. L. Bennett, M. C. Dal Canto, S. L. Kunkel, and N. W. Lukacs. 2006. Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neurovirol. 12:251-261.
44. Krizbai, I. A., and M. A. Deli. 2003. Signalling pathways regulating the tight junction permeability in the blood-brain barrier. Cell. Mol. Biol. 49:23-31.
45. Lai, C. H., K. H. Kuo, and J. M. Leo. 2005. Critical role of actin in modulating BBB permeability. Brain Res. Brain Res. Rev. 50:7-13.
46. Lee, Y. R., M. T. Liu, H. Y. Lei, C. C. Liu, J. M. Wu, Y. C. Tung, Y. S. Lin, T. M. Yeh, S. H. Chen, and H. S. Liu. 2006. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 87:3623-3630.
47. Mark, K. S., and D. W. Miller. 1999. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci. 64:1941-1953.
48. Moore, M. L., C. C. Brown, and K. R. Spindler. 2003. T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis. J. Virol. 77:10060-10070.
49. Morgan, L., B. Shah, L. E. Rivers, L. Barden, A. J. Groom, R. Chung, D. Higazi, H. Desmond, T. Smith, and J. M. Staddon. 2007. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 147:664-673. (Pubitemid 46990645)
50. Morita, K., M. Furuse, K. Fujimoto, and S. Tsukita. 1999. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96:511-516.
51. Ono, S. J., T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda. 2003. Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy Clin. Immunol. 111:1185-1199.
52. Persidsky, Y., D. Heilman, J. Haorah, M. Zelivyanskaya, R. Persidsky, G. A. Weber, H. Shimokawa, K. Kaibuchi, and T. Ikezu. 2006. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107:4770-4780. (Pubitemid 43882628)
53. Persidsky, Y., S. H. Ramirez, J. Haorah, and G. D. Kanmogne. 2006. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 1:223-236. (Pubitemid 44244128)
54. Phares, T. W., R. B. Kean, T. Mikheeva, and D. C. Hooper. 2006. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 176:7666-7675.
55. Pu, H., J. Tian, I. E. Andras, K. Hayashi, G. Flora, B. Hennig, and M. Toborek. 2005. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J. Cereb. Blood Flow Metab. 25:1325-1335.
56. Raub, T. J. 1996. Signal transduction and glial cell modulation of cultured brain microvessel endothelial cell tight junctions. Am. J. Physiol. 271:C495-C503.
57. Rubin, L. L., and J. M. Staddon. 1999. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22:11-28.
58. Sauty, A., M. Dziejman, R. A. Taha, A. S. Iarossi, K. Neote, E. A. Garcia-Zepeda, Q. Hamid, and A. D. Luster. 1999. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162:3549-3558. (Pubitemid 29313608)
59. Schaumburg, C. S., K. S. Held, and T. E. Lane. 2008. Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair. Front. Biosci. 13:4393-4406.
60. Seth, A., P. Sheth, B. C. Elias, and R. Rao. 2007. Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J. Biol. Chem. 282:11487-11498.
61. Shrestha, B., B. Zhang, W. E. Purtha, R. S. Klein, and M. S. Diamond. 2008. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J. Virol. 82:8956-8964.
62. Sikorski, E. E., R. Hallmann, E. L. Berg, and E. C. Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151:5239-5250.
63. Similä, S., R. Jouppila, A. Salmi, and R. Pohjonen. 1970. Encephalomeningitis in children associated with an adenovirus type 7 epidemic. Acta Paediatr. Scand. 59:310-316.
64. Song, L., and J. S. Pachter. 2003. Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell. Dev. Biol. Anim. 39:313-320. (Pubitemid 38200254)
65. Song, L., and J. S. Pachter. 2004. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc. Res. 67:78-89.
66. Spindler, K. R., L. Fang, M. L. Moore, C. C. Brown, G. N. Hirsch, and A. K. Kajon. 2001. SJL/J. mice are highly susceptible to infection by mouse adenovirus type 1. J. Virol. 75:12039-12046.
67. Stamatovic, S. M., R. F. Keep, S. L. Kunkel, and A. V. Andjelkovic. 2003. Potential role of MCP-1 in endothelial cell tight junction 'opening' signaling via Rho and Rho kinase. J. Cell Sci. 116:4615-4628.
68. Stamatovic, S. M., P. Shakui, R. F. Keep, B. B. Moore, S. L. Kunkel, N. Van Rooijen, and A. V. Andjelkovic. 2005. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25:593-606.
69. Stevenson, B. R., J. M. Anderson, I. D. Braun, and M. S. Mooseker. 1989. Phosphorylation of the tight-junction protein ZO-1 in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance. Biochem. J. 263:597-599.
70. Toborek, M., Y. W. Lee, G. Flora, H. Pu, I. E. Andras, E. Wylegala, B. Hennig, and A. Nath. 2005. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell. Mol. Neurobiol. 25:181-199.
71. Traweger, A., R. Fuchs, I. A. Krizbai, T. M. Weiger, H. C. Bauer, and H. Bauer. 2003. The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J. Biol. Chem. 278:2692-2700.
72. Tsao, N., H. P. Hsu, C. M. Wu, C. C. Liu, and H. Y. Lei. 2001. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 50:812-821.
73. van Hinsbergh, V. W., L. Havekes, J. J. Emeis, E. van Corven, and M. Scheffer. 1983. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis 3:547-559.
74. Vorbrodt, A. W., and D. H. Dobrogowska. 2004. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem. Cytobiol. 42:67-75.
75. Walls, T., A. G. Shankar, and D. Shingadia. 2003. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect. Dis. 3:79-86.
76. Wang, P., J. Dai, F. Bai, K. F. Kong, S. J. Wong, R. R. Montgomery, J. A. Madri, and E. Fikrig. 2008. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J. Virol. 82:8978-8985.
77. Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, and R. A. Flavell. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373.
78. Weinberg, J. B., D. R. Jensen, L. E. Gralinski, A. R. Lake, G. S. Stempfle, and K. R. Spindler. 2007. Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation. Virology 357:54-67.
79. Weinberg, J. B., G. S. Stempfle, J. E. Wilkinson, J. G. Younger, and K. R. Spindler. 2005. Acute respiratory infection with mouse adenovirus type 1. Virology 340:245-254. (Pubitemid 41317498)
80. Welton, A. R., E. J. Chesler, C. Sturkie, A. U. Jackson, G. N. Hirsch, and K. R. Spindler. 2005. Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1. J. Virol. 79:11517-11522. (Pubitemid 41170694)
81. Welton, A. R., and K. R. Spindler. 2007. Capture ELISA quantitation of mouse adenovirus type 1 in infected organs. Methods Mol. Biol. 130:215-221.
82. Wong, D., K. Dorovini-Zis, and S. R. Vincent. 2004. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp. Neurol. 190:446-455.
83. Yamamoto, M., S. H. Ramirez, S. Sato, T. Kiyota, R. L. Cerny, K. Kaibuchi, Y. Persidsky, and T. Ikezu. 2008. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol. 172:521-533.
84. Zhang, Y., D. Feigenblum, and R. J. Schneider. 1994. A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis. J. Virol. 68:7040-7050. (Pubitemid 24328754)
85. Zhang, Y., and R. J. Schneider. 1994. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 68:2544-2555. (Pubitemid 24091934)
86. Zheng, X., X. Lu, D. D. Erdman, E. J. Anderson, J. A. Guzman-Cottrill, M. Kletzel, and B. Z. Katz. 2008. Identification of adenvoiruses in specimens from high-risk pediatric stem cell transplant recipients and controls. J. Clin. Microbiol. 46:317-320.
87. Zhou, J., S. A. Stohlman, D. R. Hinton, and N. W. Marten. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170:3331-3336. (Pubitemid 36302212)